Pfizer Inc
Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales
The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Shares of Abbott Laboratories popped Wednesday after the company’s earnings and revenue topped Wall Street’s expectations, defying a dramatic slowdown in sales of its Covid-19 tests. The medical products company posted adjusted earnings per share of $1.03. […]
Read More
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
The Janssen Johnson & Johnson COVID-19 vaccine. Allen J. Schaben | Los Angeles Times | Getty Images International Covid vaccine sales helped spark Johnson & Johnson‘s revenue and earnings beat on Tuesday, but the company said it expects no sales from the shot moving forward. “Regarding our Covid-19 vaccine, we do not anticipate material sales […]
Read More
FDA authorizes additional omicron Covid booster for seniors and people with weak immune systems
Sylvester Fisher gets a influenza vaccine from pharmacist Patricia Pernal during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The vaccines were being offered along with pneumonia vaccines and the recently authorized COVID-19 booster vaccine, which protects against the original SARS-CoV-2 […]
Read More
Goldman says dividend expansion shares will outperform beneath existing situations. 10 names it endorses
Goldman Sachs claims one profits-targeted system is off to a potent begin this year, and will continue on to outperform – dividend development stocks. S & P 500 dividends grew by 8% 12 months around yr in the first quarter of 2023, according to a Friday be aware. On the other hand, buybacks dropped by […]
Read More
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill
Pfizer Chairman and CEO Albert Bourla attends a conversation during the World Economic Forum WEF 2022 Annual Meeting in Davos, Switzerland, May 25, 2022. Zheng Huansong | Xinhua News Agency | Getty Images Pfizer‘s CEO signed on to an industry letter in support of the Food and Drug Administration’s authority to regulate drugs after a […]
Read More
Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022. Xinhua News Agency | Getty Images People who receive Pfizer‘s RSV vaccine for older adults should be monitored for Guillain-Barre syndrome, after two people developed the nervous system disorder after […]
Read More
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
A Johnson & Johnson building is shown in Irvine, California. Mike Blake | Reuters Johnson & Johnson on Wednesday said it’s ducking out of the RSV vaccine race, weeks after competitors Pfizer and GSK inched closer to launching the world’s first shot against the deadly virus. J&J will stop working on its investigational RSV adult […]
Read More
BioNTech shares slip on gloomy Covid vaccine sales outlook
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Shares of BioNTech on Monday slid by more than 6% in morning trading after the German drugmaker shared a gloomy 2023 sales outlook for its […]
Read More
Pfizer signals settlement with China on improving upon health coverage in the place
Pfizer CEO Albert Bourla speaks all through the China Improvement Forum in Beijing on March 25, 2023. Lintao Zhang | Getty Photographs Information | Getty Illustrations or photos BEIJING — U.S. pharma big Pfizer has signed an settlement with China to cooperate on strengthening the country’s health coverage, according to the business. “We are aligned […]
Read More
Pfizer’s Covid drug Paxlovid may reduce the risk of developing long Covid, study says
A prescription for Pfizers Paxlovid tablets outside of his apartment in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post) Rachel Wisniewski | The Washington Post | Getty Images People who take Pfizer‘s Covid antiviral treatment Paxlovid shortly after infection may reduce their risk of developing long Covid, regardless of their […]
Read More